ISEE News and Press, IVERIC bio Inc.

2023-08-16 12:41:31 ET Summary Astellas has closed its Iveric bio, Inc. deal in July and reported JPY 375Bn in quarterly sales in Q1. The company's earnings power and asset factors are bullish, but valuation factors are keeping me neutral. From this, I am closely watching the ...

Astellas Completes Acquisition of Iveric Bio PR Newswire TOKYO and PARSIPPANY, N.J. , July 11, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura , "Astellas") today announced that it has successfully completed the acquisit...

Shares of IVERIC bio, Inc. (NASDAQ: ISEE) traded at a new 52-week high today and are currently trading at $39.73. So far today, approximately 1.78M shares have been exchanged, as compared to an average 30-day volume of 5.04M shares. IVERIC bio, Inc., a biopharmaceutical company, discovers and...

2023-06-30 15:00:00 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...

2023-06-29 21:40:12 ET Iveric Bio ( NASDAQ: ISEE ) ticked up 0.8% in after hours trading after saying it expects its sale to Astellas ( OTCPK:ALPMF ) to close on July 11. Iveric ( ISEE ) expects its $5.9 billion sale to close three business days after its shareholder...

2023-06-28 14:52:29 ET Iveric Bio ( NASDAQ: ISEE ), which agreed to be acquired by Astellas Pharmaceuticals ( OTCPK:ALPMF ) in May for $5.9 billio n, dropped as much as 8.8% , though it has now pared the loss to 3%. There is no specific reason to account for the dro...

2023-06-26 09:31:58 ET Iveric Bio ( NASDAQ: ISEE ) rose 2.2% after the HSR waiting period for its planned sale to Astellas Pharmaceuticals ( OTCPK:ALPMY ) expired. The HSR waiting period for the Iveric ( ISEE ) sale expired on Friday, according to a regulatory fili...

2023-06-05 13:51:22 ET Iveric Bio ( NASDAQ: ISEE ) rose 2% after the shareholder vote for its planned sale to Astellas Pharmaceuticals ( OTCPK:ALPMY ) was set for July 6. The July 6 date was disclosed in a proxy filing earlier on Monday. The July date is an impor...

IVERIC bio, Inc. (NASDAQ: ISEE) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 1.93% on the day to $38.77. IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal disease...

2023-05-30 15:02:46 ET Summary Iveric bio, Inc., focused on developing treatments for retinal diseases, has announced its acquisition by Astellas Pharma Inc. Iveric bio, Inc. stock trades at a discount of over 5% for an acquisition that is targeted to close in the third calendar q...